Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Germaine™ Laboratories BioSign™ Flu A/B Kit
An In vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.
$372.00 - $1904.00
Specifications
Content And Storage | 2°C to 30°C |
---|---|
CE Marker | Yes |
Clia Complexity | Waived (Nasal Swab) |
Detectable Analytes | Influenza A and B |
Includes | Positive and Negative Control Swabs |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
23-111-370
|
Germaine™ Laboratories
BSP51025P |
6 x 25 Kits = 150 Tests |
Case of 150 for $1,904.00
|
|
|||||
23-111-369
|
Germaine™ Laboratories
BSP51025 |
25 Tests |
Pack of 25 for $372.00
|
|
|||||
Description
- Differentiates between Influenza Type A & B, on a single test device
- Produces results in 10 to 15 minutes
- Each test device includes built-in controls
- Each kit comes with external controls
- Meets FDA performance criteria for influenza tests stated in code 21 CFR 866.3328
- CLIA Complexity: Moderate complexity when used with nasal wash/aspirate samples
- CLIA Waived when used with nasal and nasopharyngeal swabs
Specifications
2°C to 30°C | |
Waived (Nasal Swab) | |
Positive and Negative Control Swabs |
Yes | |
Influenza A and B |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title